About Andrew Schwab
Form D filings for RareCyte from 2019 to 2023 list Andrew Schwab as director.
Andrew Schwab first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Schwab in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Schwab works with at each company, as listed on that company's latest Form D.
RareCyte, Inc. · Form D, Jul 25, 2023
DK
David Kabakoff
Director
RS
Ronald Seubert
Director
Robert Weisskoff
Director
DM
Daniel Marshak
Director
JG
Jan Garfinkle
Director
SR
Stephen Reichenbach
Executive officer
JJ
Joseph Victor Jr.
Chief Executive Officer and director